ITCI vs. GILD
Compare and contrast key facts about Intra-Cellular Therapies, Inc. (ITCI) and Gilead Sciences, Inc. (GILD).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ITCI or GILD.
Correlation
The correlation between ITCI and GILD is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
ITCI vs. GILD - Performance Comparison
Key characteristics
ITCI:
1.72
GILD:
2.39
ITCI:
4.01
GILD:
3.36
ITCI:
1.53
GILD:
1.43
ITCI:
4.86
GILD:
2.01
ITCI:
11.21
GILD:
13.25
ITCI:
8.08%
GILD:
4.51%
ITCI:
52.51%
GILD:
25.08%
ITCI:
-87.64%
GILD:
-70.82%
ITCI:
-0.04%
GILD:
-11.51%
Fundamentals
ITCI:
$14.05B
GILD:
$132.33B
ITCI:
-$0.73
GILD:
$4.76
ITCI:
0.00
GILD:
0.22
ITCI:
20.63
GILD:
4.61
ITCI:
12.23
GILD:
6.73
ITCI:
$535.77M
GILD:
$22.06B
ITCI:
$488.71M
GILD:
$17.36B
ITCI:
-$95.53M
GILD:
$7.98B
Returns By Period
In the year-to-date period, ITCI achieves a 57.89% return, which is significantly higher than GILD's 12.48% return. Over the past 10 years, ITCI has outperformed GILD with an annualized return of 20.69%, while GILD has yielded a comparatively lower 3.59% annualized return.
ITCI
57.89%
0.09%
73.95%
80.00%
50.31%
20.69%
GILD
12.48%
-7.19%
17.72%
63.62%
9.61%
3.59%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ITCI vs. GILD — Risk-Adjusted Performance Rank
ITCI
GILD
ITCI vs. GILD - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Intra-Cellular Therapies, Inc. (ITCI) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ITCI vs. GILD - Dividend Comparison
ITCI has not paid dividends to shareholders, while GILD's dividend yield for the trailing twelve months is around 3.00%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
ITCI Intra-Cellular Therapies, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GILD Gilead Sciences, Inc. | 3.00% | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% |
Drawdowns
ITCI vs. GILD - Drawdown Comparison
The maximum ITCI drawdown since its inception was -87.64%, which is greater than GILD's maximum drawdown of -70.82%. Use the drawdown chart below to compare losses from any high point for ITCI and GILD. For additional features, visit the drawdowns tool.
Volatility
ITCI vs. GILD - Volatility Comparison
The current volatility for Intra-Cellular Therapies, Inc. (ITCI) is 0.11%, while Gilead Sciences, Inc. (GILD) has a volatility of 8.79%. This indicates that ITCI experiences smaller price fluctuations and is considered to be less risky than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ITCI vs. GILD - Financials Comparison
This section allows you to compare key financial metrics between Intra-Cellular Therapies, Inc. and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities